SequelSEC

Cannabis Bioscience International Holdings, Inc. CBIH

Services-Commercial Physical & Biological Research · CIK 0001411057 · Fiscal year ends 0531

AnnualQuarterlyTTM
Revenue
$123.63K
Fiscal year ended 2026-02-28
Operating income
-$398.82K
Fiscal year ended 2026-02-28
Free cash flow
Unavailable
Fiscal year ended 2026-02-28

Valuation, from the filing

Public float$2.90MMarket value of stock held by non-affiliates, as stated on the cover page for 2024-11-29
Float per share$0.00Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue9.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-11-29, not today, and each multiple below it uses the figures for the fiscal year ending 2025-05-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Commercial Physical & Biological Research filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.03x7th
Revenue YoY growth21.8%83th
Gross margin86.8%75th
Net margin-181.1%45th
Operating margin-139.1%50th

Cannabis Bioscience International Holdings, Inc. (CBIH) reported revenue of $123.63K and net income of -$515.29K for the fiscal year ended 2026-02-28. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Cannabis Bioscience International Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Commercial Physical & Biological Research.

Income

Cannabis Bioscience International Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-28
Revenue$123.63K
Cost of revenue$26.23K
Gross profit$97.39K
Operating income-$398.82K
Net income-$515.29K
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$31.42K
Selling & marketingUnavailable

Balance

Cannabis Bioscience International Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-28
Cash & equivalentsUnavailable
Total assets$1.54K
Current assets$1.54K
Total liabilities$1.47M
Current liabilities$1.22M
Total equity incl. NCI-$1.47M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$1.27K
GoodwillUnavailable
Long-term debt$249.50K
Accounts payableUnavailable

Cash flow

Cannabis Bioscience International Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-28
Operating cash flow-$268.11K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

Cannabis Bioscience International Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-02-28
Free cash flowUnavailable
Gross margin78.8%
Operating margin-322.6%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.00x
Revenue YoY growth-64.1%
Net margin-416.8%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CBIH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-04-16View SEC filing
10-Q · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-10-22View SEC filing
10-K · Filed 2025-09-22View SEC filing
10-Q/A · Filed 2025-05-09View SEC filing
10-Q · Filed 2024-10-21View SEC filing

Companies in the same industry

ABSI BIAF BUDZ CRL FOXO IBAC INCY IQV ISPC MEDP MXCT NRC

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.